{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:37:53Z","timestamp":1791319073028,"version":"4.3.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Endothelial dysfunction (ED) is a key factor for the development of cardiovascular diseases. Due to its chronic, life-threatening nature, ED only can be studied experimentally in animal models. Therefore, this work was aimed to characterize a murine model of ED induced by a daily intraperitoneal administration of angiotensin II (AGII) for 10\u00a0weeks. Oxidative stress, inflammation, vascular remodeling, hypertension, and damage to various target organs were evaluated in treated animals. The results indicated that a chronic intraperitoneal administration of AGII increases the production of systemic soluble VCAM, ROS and ICAM-1 expression, and the production of TNF\u03b1, IL1\u03b2, IL17A, IL4, TGF\u03b2, and IL10 in the kidney, as well as blood pressure levels; it also promotes vascular remodeling and induces non-alcoholic fatty liver disease, glomerulosclerosis, and proliferative retinopathy. Therefore, the model herein proposed can be a representative model for ED; additionally, it is easy to implement, safe, rapid, and inexpensive.<\/jats:p>","DOI":"10.1038\/s41598-021-00676-x","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T10:04:13Z","timestamp":1635329053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Characterization of a murine model of endothelial dysfunction induced by chronic intraperitoneal administration of angiotensin II"],"prefix":"10.1038","volume":"11","author":[{"given":"Celeste","family":"Trejo-Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Jim\u00e9nez-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Castro-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"M\u00e9ndez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Ang\u00e9lica","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Arrell\u00edn-Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Pedraza-Chaverri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Noel","family":"Medina-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Hern\u00e1ndez-T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Ram\u00edrez-Pliego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Herrera-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelynne","family":"Cervantes-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimri Aziel","family":"Alvarado-Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Costet-Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladis","family":"Fragoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Rosas-Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"key":"676_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2840-5-4","volume":"5","author":"RJ Esper","year":"2006","unstructured":"Esper, R. J. et al. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc. Diabetol. 5, 4. https:\/\/doi.org\/10.1186\/1475-2840-5-4 (2006).","journal-title":"Cardiovasc. Diabetol."},{"key":"676_CR2","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","volume":"15","author":"DH Endemann","year":"2004","unstructured":"Endemann, D. H. & Schiffrin, E. L. Endothelial dysfunction. J. Am. Soc. Nephrol. 15, 1983\u20131992. https:\/\/doi.org\/10.1097\/01.ASN.0000132474.50966.DA (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"676_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00395-019-0717-2","volume":"114","author":"S Kr\u00f6ller-Sch\u00f6n","year":"2019","unstructured":"Kr\u00f6ller-Sch\u00f6n, S. et al. Endothelial \u03b11AMPK modulates angiotensin II-mediated vascular inflammation and dysfunction. Basic Res. Cardiol. 114, 8. https:\/\/doi.org\/10.1007\/s00395-019-0717-2 (2019).","journal-title":"Basic Res. Cardiol."},{"key":"676_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s13577-018-0220-3","volume":"32","author":"H Dong","year":"2019","unstructured":"Dong, H., Ming, S., Fang, J., Li, Y. & Liu, L. Icariin ameliorates angiotensin II-induced cerebrovascular remodeling by inhibiting Nox2-containing NADPH oxidase activation. Hum. Cell. 32, 22\u201330. https:\/\/doi.org\/10.1007\/s13577-018-0220-3 (2019).","journal-title":"Hum. Cell."},{"key":"676_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1161\/CIRCRESAHA.107.150474","volume":"101","author":"N Henke","year":"2007","unstructured":"Henke, N. et al. Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage. Circ. Res. 101, 268\u2013276. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.150474 (2007).","journal-title":"Circ. Res."},{"key":"676_CR6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2147\/JIR.S275595","volume":"13","author":"J Checa","year":"2020","unstructured":"Checa, J. & Aran, J. M. Reactive Oxygen Species: Drivers of Physiological and Pathological Processes. J Inflamm Res. 13, 1057\u20131073. https:\/\/doi.org\/10.2147\/JIR.S275595 (2020).","journal-title":"J Inflamm Res."},{"key":"676_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbagrm.2015.11.001","volume":"1859","author":"HL Yang","year":"2016","unstructured":"Yang, H. L. et al. Coenzyme Q0 regulates NF\u03baB\/AP-1 activation and enhances Nrf2 stabilization in attenuation of LPS-induced inflammation and redox imbalance: Evidence from in vitro and in vivo studies. Biochim Biophys Acta. 1859, 246\u2013261. https:\/\/doi.org\/10.1016\/j.bbagrm.2015.11.001 (2016).","journal-title":"Biochim Biophys Acta."},{"key":"676_CR8","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1089\/ars.2005.7.1302","volume":"7","author":"RM Touyz","year":"2005","unstructured":"Touyz, R. M. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid. Redox. Signal. 7, 1302\u20131314. https:\/\/doi.org\/10.1089\/ars.2005.7.1302 (2005).","journal-title":"Antioxid. Redox. Signal."},{"key":"676_CR9","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s12038-011-9097-y","volume":"36","author":"WC Dornas","year":"2011","unstructured":"Dornas, W. C. & Silva, M. E. Animal models for the study of arterial hypertension. J. Biosci. 36, 731\u2013737. https:\/\/doi.org\/10.1007\/s12038-011-9097-y (2011).","journal-title":"J. Biosci."},{"key":"676_CR10","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1084\/jem.20070657","volume":"204","author":"TJ Guzik","year":"2007","unstructured":"Guzik, T. J. et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204, 2449\u20132460. https:\/\/doi.org\/10.1084\/jem.20070657 (2007).","journal-title":"J. Exp. Med."},{"key":"676_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035632","volume":"7","author":"N Wang","year":"2012","unstructured":"Wang, N. et al. Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2. PLoS ONE 7, e35632. https:\/\/doi.org\/10.1371\/journal.pone.0035632 (2012).","journal-title":"PLoS ONE"},{"key":"676_CR12","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1126\/science.149.3690.1394","volume":"149","author":"JW McCubbin","year":"1965","unstructured":"McCubbin, J. W., DeMoura, R. S., Page, I. H. & Olmsted, F. Arterial hypertension elicited by subpressor amounts of angiotensin. Science 149, 1394\u20131395. https:\/\/doi.org\/10.1126\/science.149.3690.1394 (1965).","journal-title":"Science"},{"key":"676_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jep.2010.05.013","volume":"130","author":"ACE inhibition and angiotensin II a","year":"2010","unstructured":"ACE inhibition and angiotensin II antagonism.,. Jim\u00e9nez-Ferrer, E., Badillo, F. H., Gonz\u00e1lez-Cortazar, M., Tortoriello, J., & Herrera-Ruiz, M. Antihypertensive activity of Salvia elegans Vahl. (Lamiaceae). J. Ethnopharmacol. 130, 340\u2013346. https:\/\/doi.org\/10.1016\/j.jep.2010.05.013 (2010).","journal-title":"J. Ethnopharmacol."},{"key":"676_CR14","doi-asserted-by":"publisher","unstructured":"Lombardo-Earl, G., et al. Extracts and Fractions from Edible Roots of Sechium edule (Jacq.) Sw. with Antihypertensive Activity.\u00a0Evid Based Complement Alternat Med.\u00a02014, 594326. https:\/\/doi.org\/10.1155\/2014\/594326 (2014).","DOI":"10.1155\/2014\/594326"},{"key":"676_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1365-2141.2005.05701.x","volume":"130","author":"GJ Kato","year":"2005","unstructured":"Kato, G. J. et al. Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br. J. Haematol. 130, 943\u2013953. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05701.x (2005).","journal-title":"Br. J. Haematol."},{"key":"676_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1089\/ars.2006.8.691","volume":"8","author":"AC Cave","year":"2006","unstructured":"Cave, A. C. et al. NADPH oxidases in cardiovascular health and disease. Antioxid. Redox. Signal. 8, 691\u2013728. https:\/\/doi.org\/10.1089\/ars.2006.8.691 (2006).","journal-title":"Antioxid. Redox. Signal."},{"key":"676_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.biopha.2017.06.036","volume":"93","author":"M Lind","year":"2017","unstructured":"Lind, M. et al. Inducible nitric oxide synthase: Good or bad?. Biomed. Pharmacother. 93, 370\u2013375. https:\/\/doi.org\/10.1016\/j.biopha.2017.06.036 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"676_CR18","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00395-008-0733-0","volume":"103","author":"C Zhang","year":"2008","unstructured":"Zhang, C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res. Cardiol. 103, 398\u2013406. https:\/\/doi.org\/10.1007\/s00395-008-0733-0 (2008).","journal-title":"Basic Res. Cardiol."},{"key":"676_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.vph.2019.01.004","volume":"115","author":"S Masi","year":"2019","unstructured":"Masi, S., Uliana, M. & Virdis, A. Angiotensin II and vascular damage in hypertension: Role of oxidative stress and sympathetic activation. Vascul. Pharmacol. 115, 13\u201317. https:\/\/doi.org\/10.1016\/j.vph.2019.01.004 (2019).","journal-title":"Vascul. Pharmacol."},{"key":"676_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1161\/HYPERTENSIONAHA.115.06737","volume":"67","author":"SP Didion","year":"2016","unstructured":"Didion, S. P. New insights into mechanisms associated with angiotensin II-induced vascular hypertrophy and remodeling. Hypertension 67, 501\u2013503. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06737 (2016).","journal-title":"Hypertension"},{"key":"676_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cardiores.2003.11.037","volume":"61","author":"AD Struthers","year":"2004","unstructured":"Struthers, A. D. & MacDonald, T. M. Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc. Res. 61, 663\u2013670. https:\/\/doi.org\/10.1016\/j.cardiores.2003.11.037 (2004).","journal-title":"Cardiovasc. Res."},{"key":"676_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00041552-200105000-00005","volume":"10","author":"M Ruiz-Ortega","year":"2001","unstructured":"Ruiz-Ortega, M., Lorenzo, O., Suzuki, Y., Rup\u00e9rez, M. & Egido, J. Proinflammatory actions of angiotensins. Curr. Opin. Nepphrol. Hypertens. 10, 321\u2013329. https:\/\/doi.org\/10.1097\/00041552-200105000-00005 (2001).","journal-title":"Curr. Opin. Nepphrol. Hypertens."},{"key":"676_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000174085","volume":"19","author":"KF Hilgers","year":"1996","unstructured":"Hilgers, K. F. & Mann, J. F. Role of angiotensin II in glomerular injury: Lessons from experimental and clinical studies. Kidney Blood Press Res. 19, 254\u2013262. https:\/\/doi.org\/10.1159\/000174085 (1996).","journal-title":"Kidney Blood Press Res."},{"key":"676_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster, S., Cabrera, D., Arrese, M. & Feldstein, A. E. Triggering and resolution of inflammation in NASH. Nat. Rev. Gastroenterol. Hepatol. 15, 349\u2013364. https:\/\/doi.org\/10.1038\/s41575-018-0009-6 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"676_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3389\/fendo.2020.00591","volume":"11","author":"F Gui","year":"2020","unstructured":"Gui, F., You, Z., Fu, S., Wu, H. & Zhang, Y. Endothelial dysfunction in diabetic retinopathy. Front. Endocrinol. Lausanne 11, 591. https:\/\/doi.org\/10.3389\/fendo.2020.00591 (2020).","journal-title":"Front. Endocrinol. Lausanne"},{"key":"676_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161706","volume":"11","author":"D Karanovic","year":"2016","unstructured":"Karanovic, D. et al. Effects of single and combined losartan and tempol treatments on oxidative stress, kidney structure and function in spontaneously hypertensive rats with early course of proteinuric nephropathy. PLoS ONE 11, e0161706. https:\/\/doi.org\/10.1371\/journal.pone.0161706 (2016).","journal-title":"PLoS ONE"},{"key":"676_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/HYPERTENSIONAHA.111.188136","volume":"59","author":"D Deliyanti","year":"2012","unstructured":"Deliyanti, D. et al. Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy. Hypertension 59, 607\u2013613. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.188136 (2012).","journal-title":"Hypertension"},{"key":"676_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000107376","volume":"24","author":"G Zalba","year":"2007","unstructured":"Zalba, G. et al. Oxidative stress, endothelial dysfunction and cerebrovascular disease. Cerebrovasc. Dis. 24, 24\u201329. https:\/\/doi.org\/10.1159\/000107376 (2007).","journal-title":"Cerebrovasc. Dis."},{"key":"676_CR29","doi-asserted-by":"publisher","unstructured":"Morton, D. B., et al. Refining procedures for the administration of substances. Report of the BVAAWF\/FRAME\/RSPCA\/UFAW Joint Working Group on Refinement. British Veterinary Association Animal Welfare Foundation\/Fund for the Replacement of Animals in Medical Experiments\/Royal Society for the Prevention of Cruelty to Animals\/Universities Federation for Animal Welfare. Lab. Anim.\u00a035, 1\u201341. https:\/\/doi.org\/10.1258\/0023677011911345 (2001).","DOI":"10.1258\/0023677011911345"},{"key":"676_CR30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1254\/jphs.fmj04006x5","volume":"96","author":"S Kimura","year":"2004","unstructured":"Kimura, S., Zhang, G. X. & Abe, Y. Malfunction of vascular control in lifestyle-related diseases: Oxidative stress of angiotensin II-induced hypertension: Mitogen-activated protein kinases and blood pressure regulation. J. Pharmacol. Sci. 96, 406\u2013410. https:\/\/doi.org\/10.1254\/jphs.fmj04006x5 (2004).","journal-title":"J. Pharmacol. Sci."},{"key":"676_CR31","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1042\/CS20210094","volume":"135","author":"KN Miyata","year":"2021","unstructured":"Miyata, K. N. et al. Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice. Clin. Sci. 135, 943\u2013961. https:\/\/doi.org\/10.1042\/CS20210094 (2021).","journal-title":"Clin. Sci."},{"key":"676_CR32","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.bbrc.2011.06.021","volume":"410","author":"S Xu","year":"2011","unstructured":"Xu, S., Zhi, H., Hou, X. & Jiang, B. Angiotensin II modulates interleukin-1\u03b2-induced inflammatory gene expression in vascular smooth muscle cells via interfering with ERK-NF-\u03baB crosstalk. Biochem. Biophys. Res. Commun. 410, 543\u2013548 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"676_CR33","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.avsg.2020.03.002","volume":"67","author":"J Yue","year":"2020","unstructured":"Yue, J., Yin, L., Shen, J. & Liu, Z. A modified murine abdominal aortic aneurysm rupture model using elastase perfusion and angiotensin II infusion. Ann. Vasc. Surg. 67, 474\u2013481. https:\/\/doi.org\/10.1016\/j.avsg.2020.03.002 (2020).","journal-title":"Ann. Vasc. Surg."},{"key":"676_CR34","doi-asserted-by":"publisher","first-page":"G147","DOI":"10.1152\/ajpgi.00462.2007","volume":"296","author":"M Moreno","year":"2009","unstructured":"Moreno, M. et al. Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G147\u2013G156. https:\/\/doi.org\/10.1152\/ajpgi.00462.2007 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"676_CR35","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1161\/01.ATV.0000258415.32883.bf","volume":"27","author":"U Landmesser","year":"2007","unstructured":"Landmesser, U. et al. Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease. Arterioscler. Thromb. Vasc. Biol. 27, 943\u2013948. https:\/\/doi.org\/10.1161\/01.ATV.0000258415.32883.bf (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"676_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1023\/a:1020714518246","volume":"7","author":"M de Gasparo","year":"2002","unstructured":"de Gasparo, M. Angiotensin II and nitric oxide interaction. Heart Fail. Rev. 7, 347\u2013358. https:\/\/doi.org\/10.1023\/a:1020714518246 (2002).","journal-title":"Heart Fail. Rev."},{"key":"676_CR37","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1161\/hq1001.097028","volume":"21","author":"H Cai","year":"2001","unstructured":"Cai, H., Davis, M. E., Drummond, G. R. & Harrison, D. G. Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)\/calmodulin-dependent protein kinase II\/janus kinase 2-dependent pathway. Arterioscler. Thromb. Vasc. Biol. 21, 1571\u20131576. https:\/\/doi.org\/10.1161\/hq1001.097028 (2001).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"676_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1042\/BJ20061903","volume":"406","author":"L Serrander","year":"2007","unstructured":"Serrander, L. et al. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem. J. 406, 105\u2013114. https:\/\/doi.org\/10.1042\/BJ20061903 (2007).","journal-title":"Biochem. J."},{"key":"676_CR39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fphys.2012.00140","volume":"3","author":"J Zhang","year":"2012","unstructured":"Zhang, J. et al. NOX4-dependent hydrogen peroxide overproduction in human atrial fibrillation and HL-1 atrial cells: Relationship to hypertension. Front. Physiol. 3, 140. https:\/\/doi.org\/10.3389\/fphys.2012.00140 (2012).","journal-title":"Front. Physiol."},{"key":"676_CR40","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1161\/ATVBAHA.108.164277","volume":"28","author":"N Anilkumar","year":"2008","unstructured":"Anilkumar, N., Weber, R., Zhang, M., Brewer, A. & Shah, A. M. Nox4 and nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation. Arterioscler. Thromb. Vasc. Biol. 28, 1347\u20131354. https:\/\/doi.org\/10.1161\/ATVBAHA.108.164277 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"676_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.coemr.2020.07.011","volume":"16","author":"CA Birch","year":"2021","unstructured":"Birch, C. A., Molinar-Inglis, O. & Trejo, J. Subcellular hot spots of GPCR signaling promote vascular inflammation. Curr. Opin. Endocr. Metab. Res. 16, 37\u201342. https:\/\/doi.org\/10.1016\/j.coemr.2020.07.011 (2021).","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"676_CR42","doi-asserted-by":"publisher","first-page":"30708","DOI":"10.1074\/jbc.M110.126433","volume":"285","author":"P Doyon","year":"2010","unstructured":"Doyon, P. & Servant, M. J. Tumor necrosis factor receptor-associated factor-6 and ribosomal S6 kinase intracellular pathways link the angiotensin II AT1 receptor to the phosphorylation and activation of the IkappaB kinase complex in vascular smooth muscle cells. J. Biol. Chem. 285, 30708\u201330718. https:\/\/doi.org\/10.1074\/jbc.M110.126433 (2010).","journal-title":"J. Biol. Chem."},{"key":"676_CR43","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1074\/jbc.M009160200","volume":"276","author":"S Frantz","year":"2001","unstructured":"Frantz, S., Kelly, R. A. & Bourcier, T. Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes. J. Biol. Chem. 276, 5197\u20135203. https:\/\/doi.org\/10.1074\/jbc.M009160200 (2001).","journal-title":"J. Biol. Chem."},{"key":"676_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2020.124050","volume":"404","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Amorphous silica nanoparticles induce inflammation via activation of NLRP3 inflammasome and HMGB1\/TLR4\/MYD88\/NF-kb signaling pathway in HUVEC cells. J. Hazard Mater. 404, 124050. https:\/\/doi.org\/10.1016\/j.jhazmat.2020.124050 (2021).","journal-title":"J. Hazard Mater."},{"key":"676_CR45","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/nu10030276","volume":"10","author":"C Trejo-Moreno","year":"2018","unstructured":"Trejo-Moreno, C. et al. Cucumis sativus aqueous fraction inhibits angiotensin II-induced inflammation and oxidative stress in vitro. Nutrients 10, 276. https:\/\/doi.org\/10.3390\/nu10030276 (2018).","journal-title":"Nutrients"},{"key":"676_CR46","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/01.ATV.0000168896.64927.bb","volume":"25","author":"T M\u00fcnzel","year":"2005","unstructured":"M\u00fcnzel, T., Daiber, A., Ullrich, V. & M\u00fclsch, A. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler. Thromb. Vasc. Biol. 25, 1551\u20131557. https:\/\/doi.org\/10.1161\/01.ATV.0000168896.64927.bb (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"676_CR47","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1083\/jcb.201903090","volume":"218","author":"RJ Schulze","year":"2019","unstructured":"Schulze, R. J., Schott, M. B., Casey, C. A., Tuma, P. L. & McNiven, M. A. The cell biology of the hepatocyte: A membrane trafficking machine. J. Cell Biol. 218, 2096\u20132112. https:\/\/doi.org\/10.1083\/jcb.201903090 (2019).","journal-title":"J. Cell Biol."},{"key":"676_CR48","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.7150\/ijms.6635","volume":"10","author":"KL Ma","year":"2013","unstructured":"Ma, K. L. et al. Interaction of RAS activation and lipid disorders accelerates the progression of glomerulosclerosis. Int. J. Med. Sci. 10, 1615\u20131624 (2013).","journal-title":"Int. J. Med. Sci."},{"key":"676_CR49","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2337\/diabetes.54.4.991","volume":"54","author":"L Yvan-Charvet","year":"2005","unstructured":"Yvan-Charvet, L. et al. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 54, 991\u2013999. https:\/\/doi.org\/10.2337\/diabetes.54.4.991 (2005).","journal-title":"Diabetes"},{"key":"676_CR50","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2008.08.068","volume":"375","author":"M Sekiya","year":"2008","unstructured":"Sekiya, M., Hiraishi, A., Touyama, M. & Sakamoto, K. Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells. Biochem. Biophys. Res. Commun. 375, 602\u2013607. https:\/\/doi.org\/10.1016\/j.bbrc.2008.08.068 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"676_CR51","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.cgh.2006.06.011","volume":"4","author":"VW Wong","year":"2006","unstructured":"Wong, V. W. et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 4, 1154\u20131161. https:\/\/doi.org\/10.1016\/j.cgh.2006.06.011 (2006).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"676_CR52","doi-asserted-by":"publisher","first-page":"298S","DOI":"10.1097\/01.alc.0000191810.46000.37","volume":"29","author":"K Tokushige","year":"2005","unstructured":"Tokushige, K. et al. Clinical significance of soluble TNF receptor in Japanese patients with non-alcoholic steatohepatitis. Alcohol Clin. Exp. Res. 29, 298S-303S. https:\/\/doi.org\/10.1097\/01.alc.0000191810.46000.37 (2005).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"676_CR53","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1172\/JCI18212","volume":"112","author":"R Bataller","year":"2003","unstructured":"Bataller, R. et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J. Clin. Invest. 112, 1383\u20131394. https:\/\/doi.org\/10.1172\/JCI18212 (2003).","journal-title":"J. Clin. Invest."},{"key":"676_CR54","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/jir.2010.0073","volume":"31","author":"F Guo","year":"2011","unstructured":"Guo, F. et al. Role of angiotensin II type 1 receptor in angiotensin II-induced cytokine production in macrophages. J. Interferon Cytokine Res. 31, 351\u2013361. https:\/\/doi.org\/10.1089\/jir.2010.0073 (2011).","journal-title":"J. Interferon Cytokine Res."},{"key":"676_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1872-034X.2009.00581.x","volume":"40","author":"A Lugo-Baruqui","year":"2010","unstructured":"Lugo-Baruqui, A., Mu\u00f1oz-Valle, J. F., Ar\u00e9valo-Gallegos, S. & Armend\u00e1riz-Borunda, J. Role of angiotensin II in liver fibrosis-induced portal hypertension and therapeutic implications. Hepatol. Res. 40, 95\u2013104. https:\/\/doi.org\/10.1111\/j.1872-034X.2009.00581.x (2010).","journal-title":"Hepatol. Res."},{"key":"676_CR56","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.326.7395.924","volume":"326","author":"PJ Watkins","year":"2003","unstructured":"Watkins, P. J. Retinopathy. BMJ 326, 924\u2013926. https:\/\/doi.org\/10.1136\/bmj.326.7395.924 (2003).","journal-title":"BMJ"},{"key":"676_CR57","first-page":"51","volume":"37","author":"M Tomi\u0107","year":"2013","unstructured":"Tomi\u0107, M., Ljubi\u0107, S. & Kastelan, S. The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy. Coll. Antropol. 37, 51\u201357 (2013).","journal-title":"Coll. Antropol."},{"key":"676_CR58","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.biocel.2005.08.002","volume":"38","author":"JL Wilkinson-Berka","year":"2006","unstructured":"Wilkinson-Berka, J. L. Angiotensin and diabetic retinopathy. Int. J. Biochem. Cell Biol. 38, 752\u2013765. https:\/\/doi.org\/10.1016\/j.biocel.2005.08.002 (2006).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"676_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019203","volume":"6","author":"FZ Marques","year":"2011","unstructured":"Marques, F. Z. et al. Genes influencing circadian differences in blood pressure in hypertensive mice. PLoS ONE 6, e19203. https:\/\/doi.org\/10.1371\/journal.pone.0019203 (2011).","journal-title":"PLoS ONE"},{"key":"676_CR60","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ki.1984.147","volume":"26","author":"L Raij","year":"1984","unstructured":"Raij, L., Azar, S. & Keane, W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 26, 137\u2013143. https:\/\/doi.org\/10.1038\/ki.1984.147 (1984).","journal-title":"Kidney Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00676-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00676-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00676-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:55:14Z","timestamp":1670086514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00676-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["676"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-00676-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"13 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21193"}}